πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 793 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6627189

Inhibition of cellular proliferation using ras antisense molecules

The Board of Regents of the University of Texas System Β· Granted Tue Sep 30 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6617102

Tankyrase H, compositions involved in the cell cycle and methods of use

Rigel Pharmaceuticals, Inc. Β· Granted Tue Sep 09 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6617331

Purine inhibitors of protein kinases, G proteins and polymerases

The Regents of the University of California Β· Granted Tue Sep 09 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6617110

Cells immortalized with telomerase reverse transcriptase for use in drug screening

The Regents of the University of Technology Office of Technology Transfer Β· Granted Tue Sep 09 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6608087

Gyrase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated Β· Granted Tue Aug 19 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6593119

Core 2 &bgr;-1,6-N-acetylglycosaminyltransferase gene

GlycoDesign Holdings Ltd. Β· Granted Tue Jul 15 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6593306

Methods for modulation and inhibition of telomerase

The Board of Regents of the University of Texas System Β· Granted Tue Jul 15 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6589725

Tankyrase H, compositions involved in the cell cycle and methods of use

Rigel Pharmaceuticals, Inc. Β· Granted Tue Jul 08 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6585960

Abrasive silica compositions and dentifrice compositions prepared therefrom

W.R. Grace & Co.-Conn. Β· Granted Tue Jul 01 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6579695

Phosphopantetheinyl transferases and uses thereof

The Regents of the University of California Β· Granted Tue Jun 17 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6555669

Human transferase proteins and polynucleotides encoding the same

Lexicon Genetics, Inc. Β· Granted Tue Apr 29 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6551774

Diagnostic methods for conditions associated with elevated cellular levels of telomerase a

The Board of Regents of the University of Texas System Β· Granted Tue Apr 22 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6552053

Controlling attention and memory by altering neuronal carbonic anhydrase activity

The United States of America, as represented by the Secretary, Health and Human Services Β· Granted Tue Apr 22 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6548521

Inhibitors of metazoan parasite proteases

The Regents of the University of California Β· Granted Tue Apr 15 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6537814

Compositions and methods for altering the biodistribution of biological agents

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA Β· Granted Tue Mar 25 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6509444

Serum amyloid a isoform from colostrum

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA Β· Granted Tue Jan 21 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6498019

Lecithin-cholesterol acyltransferase protein

Takeda Chemical Industries Ltd. Β· Granted Tue Dec 24 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6492152

Core 1 &bgr;3-galactosyl transferases and methods of use thereof

The Board of Regents of the University of Oklahoma Β· Granted Tue Dec 10 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6475789

Human telomerase catalytic subunit: diagnostic and therapeutic methods

The Regents of the University of Technology Office of Technology Transfer Β· Granted Tue Nov 05 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6476037

L-arginine and phosphodiesterase (PDE) inhibitor synergism

The Regents of the University of California Β· Granted Tue Nov 05 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6469027

N-methyl-D-aspartate (NMDA) receptor blockers for the prevention of atherosclerosis

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA Β· Granted Tue Oct 22 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6468983

RNase L activators and antisense oligonucleotides effective to treat telomerase-expressing

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Oct 22 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6465614

High-affinity response-selective C-terminal analogs of C5a anaphylatoxin

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA Β· Granted Tue Oct 15 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 10 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6444650

Antisense compositions for detecting and inhibiting telomerase reverse transcriptase

The Regents of the University of Technology Office of Technology Transfer Β· Granted Tue Sep 03 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired